BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 29688269)

  • 1. Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages.
    Lima PDA; Nivet AL; Wang Q; Chen YA; Leader A; Cheung A; Tzeng CR; Tsang BK
    Biol Reprod; 2018 Oct; 99(4):838-852. PubMed ID: 29688269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemerin, a novel regulator of follicular steroidogenesis and its potential involvement in polycystic ovarian syndrome.
    Wang Q; Kim JY; Xue K; Liu JY; Leader A; Tsang BK
    Endocrinology; 2012 Nov; 153(11):5600-11. PubMed ID: 22948218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemerin suppresses ovarian follicular development and its potential involvement in follicular arrest in rats treated chronically with dihydrotestosterone.
    Kim JY; Xue K; Cao M; Wang Q; Liu JY; Leader A; Han JY; Tsang BK
    Endocrinology; 2013 Aug; 154(8):2912-23. PubMed ID: 23696570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperandrogenic environment regulates the function of ovarian granulosa cells by modulating macrophage polarization in PCOS.
    Chen X; Hong L; Diao L; Yin T; Liu S
    Am J Reprod Immunol; 2024 May; 91(5):e13854. PubMed ID: 38716832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated chemerin induces insulin resistance in human granulosa-lutein cells from polycystic ovary syndrome patients.
    Li X; Zhu Q; Wang W; Qi J; He Y; Wang Y; Lu Y; Wu H; Ding Y; Sun Y
    FASEB J; 2019 Oct; 33(10):11303-11313. PubMed ID: 31311314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of chemerin and CMKLR1 in the progesterone decrease by PCOS granulosa cells.
    Estienne A; Mellouk N; Bongrani A; Plotton I; Langer I; Ramé C; Petit C; Guérif F; Froment P; Dupont J
    Reproduction; 2021 Oct; 162(6):427-436. PubMed ID: 34605770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of obesity-associated upregulation of chemerin/chemokine-like receptor 1 in oxidative stress and apoptosis in ovaries and granulosa cells.
    Yao J; Li Z; Fu Y; Wu R; Wang Y; Liu C; Yang L; Zhang H
    Biochem Biophys Res Commun; 2019 Mar; 510(3):449-455. PubMed ID: 30722991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The polycystic ovary syndrome-associated gene Yap1 is regulated by gonadotropins and sex steroid hormones in hyperandrogenism-induced oligo-ovulation in mouse.
    Ji SY; Liu XM; Li BT; Zhang YL; Liu HB; Zhang YC; Chen ZJ; Liu J; Fan HY
    Mol Hum Reprod; 2017 Oct; 23(10):698-707. PubMed ID: 28961951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High concentration of chemerin caused by ovarian hyperandrogenism may lead to poor IVF outcome in polycystic ovary syndrome: a pilot study.
    Wang Y; Huang R; Li X; Zhu Q; Liao Y; Tao T; Kang X; Liu W; Li S; Sun Y
    Gynecol Endocrinol; 2019 Dec; 35(12):1072-1077. PubMed ID: 31155988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMKLR1 deficiency maintains ovarian steroid production in mice treated chronically with dihydrotestosterone.
    Tang M; Huang C; Wang YF; Ren PG; Chen L; Xiao TX; Wang BB; Pan YF; Tsang BK; Zabel BA; Ma BH; Zhao HY; Zhang JV
    Sci Rep; 2016 Feb; 6():21328. PubMed ID: 26893072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulosa cell-derived miR-379-5p regulates macrophage polarization in polycystic ovarian syndrome.
    Salehi R; Asare-Werehene M; Wyse BA; Abedini A; Pan B; Gutsol A; Jahangiri S; Szaraz P; Burns KD; Vanderhyden B; Li J; Burger D; Librach CL; Tsang BK
    Front Immunol; 2023; 14():1104550. PubMed ID: 37033997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian Expression of Adipokines in Polycystic Ovary Syndrome: A Role for Chemerin, Omentin, and Apelin in Follicular Growth Arrest and Ovulatory Dysfunction?
    Bongrani A; Mellouk N; Rame C; Cornuau M; Guérif F; Froment P; Dupont J
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
    Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E
    Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome.
    Li Y; Zheng Q; Sun D; Cui X; Chen S; Bulbul A; Liu S; Yan Q
    J Cell Physiol; 2019 May; 234(5):7435-7447. PubMed ID: 30580448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
    Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
    Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology.
    Krishnan A; Muthusami S; Periyasamy L; Stanley JA; Gopalakrishnan V; Ramachandran I
    Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32120970
    [No Abstract]   [Full Text] [Related]  

  • 17. N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway.
    Jing YX; Li HX; Yue F; Li YM; Yu X; He JJ; Zhang XH
    Gynecol Endocrinol; 2023 Oct; 39(1):2276167. PubMed ID: 37931646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanin regulates oxidative stress in the ovaries of polycystic ovary syndrome patients via the Keap1/Nrf2 pathway.
    Wang Y; Li N; Zeng Z; Tang L; Zhao S; Zhou F; Zhou L; Xia W; Zhu C; Rao M
    Mol Hum Reprod; 2021 Feb; 27(2):. PubMed ID: 33337472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome.
    Caldwell ASL; Edwards MC; Desai R; Jimenez M; Gilchrist RB; Handelsman DJ; Walters KA
    Proc Natl Acad Sci U S A; 2017 Apr; 114(16):E3334-E3343. PubMed ID: 28320971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.